Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
Sam Mbunya, Principal Consultant at Dr Mbunya Health and Leadership Consultancy, shared on LinkedIn:
”Congratulations, Cyrus!
A heartfelt congratulations to Njuguna Githinji, on joining the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation as a Programme Manager – East Africa.
I have had the privilege of knowing and working with Cyrus since 2015 through the AMPATH Kenya/Innovative Hematology, Inc. partnership, and over the years as my successor as Program Administrator, I have witnessed his commitment to strengthening healthcare systems, building meaningful partnerships, and improving outcomes for patients and communities.
This appointment is both well deserved and exciting for the region. As the Foundation continues its important work in haemophilia, sickle cell disease and other haemoglobinopathies, I am confident that Cyrus will bring valuable experience, leadership and a strong understanding of the East African healthcare landscape to this role.
Cyrus, congratulations on this important milestone. I look forward to continuing to work alongside you and seeing the impact of your leadership across East Africa and beyond.
Wishing you every success in this new chapter. Hongera sana, my brother.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests
-
Aug 26, 2026, 17:46Bruno Pougault: The Hidden Burden of Hemostatic Disorders in Women
-
Aug 26, 2026, 17:39Charan Gubba: Adult ITP – A major shift in the 2026 ASH Guidelines
-
Aug 26, 2026, 17:38Stephan A Mayer: Early Imaging Reveals Higher Risk of Hematoma Expansion After ICH
-
Aug 26, 2026, 17:09Kemal Karaagac: NOACs May Offer Cognitive and Clinical Benefits in AF With Alzheimer’s Disease
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population